- Project Summary
- Study Duration
- Objectives
- Team Members
Project Summary
The purpose of this study is to evaluate the safety and effectiveness of Ketotifen and Indomethacin taken together to improve symptoms related with COVID-19. Ketotifen and Indomethacin are medications approved to treat diseases other than COVID-19.
Study Duration
Till target participants are met
Objectives
“To evaluate the safety of ketotifen fumarate and indomethacin, in combination, in COVID-19 patients. 2. To investigate the effectiveness of Ketotifen fumarate and Indomethacin for improving clinical measures of respiratory function and /or resolution of COVID-19 symptoms.”
Team Members
Principal Investigator(s):Â Prof. Dr. Rajeev Shrestha
Co-Principal Investigator(s):Â Dr. Ram Bahadur Gurung
Co-Investigator(s):Â Dr. Dipesh Tamrakar, Dr. Nirish Vaidya, Dr. Samita Adhikary, Dr. Shristi Jonchhe, Dr. Pranodan Poudel, Dr. Prabin Poudel, Mr. Surendra K Madhup
Project Coordinator:Â Dr. Samita Adhikary
Research Assistants:Â Sunita Shrestha, Pooja Tamang, Melina Thapa, Shishir Ranjitkar, Reena Kharbujha, Rasmi Koirala, Arati Kuikel
Collaborating Partners:Â Sen-Jam Pharmaceutical





For more detailed Information, Please contact:Â rajeev.shrestha@kusms.edu.np/rmaleku@hotmail.com or dipesht@kusms.edu.np